Cancer Research UK

Elsevier has established a funding body agreement with Cancer Research UK to help authors publishing in Elsevier journals comply and to facilitate a successful implementation of their policy. Details about how to comply are outlined below.


Cancer Research UK requires electronic copies of any research articles that have been accepted for publication in a peer-reviewed journal, to be made available through Europe PubMed Central (Europe PMC) as soon as possible and no later than six months after final publication. Authors can comply by publishing gold open access in either an Elsevier open access or hybrid journal after paying an APC, or by publishing subscription and using the green open access route in any journal which allows authors to self-archive their accepted manuscripts in Europe PMC after an embargo period of no more than 6 months.

  • Authors can choose to publish gold open access in Elsevier’s open access or hybrid journals. This includes journals published by The Lancet.
  • When publishing open access, the corresponding author will be given a choice of two Creative Commons licenses. Cancer Research UK policy states that authors are required to select a Creative Commons Attribution (CC-BY) license.
  • An article publication charge (APC) is required to be paid in order to make an article open access. Elsevier's APCs range between c$150 and c$6,000 US Dollars excluding tax and are journal specific; please refer to the guide for authors on the journal homepage. Cancer Research UK provide designated funds to support the payment of APCs, as members of the Charity Open Access Fund (COAF). Authors can find out more about how to access COAF funding by applying through their institution here. Cancer Research UK does not provide additional funding for its institutes.
  • Upon final publication, Elsevier will immediately send to Europe PMC the final published journal article (PJA) as it appears on ScienceDirect. Europe PMC should link back to the final version of the article hosted on ScienceDirect, via its DOI, so that the article can be cited.
  • Cancer Research UK funded authors who do not have funds available for gold open access can self-archive their accepted manuscript on Europe PMC after the embargo period for their specific journal has expired. Accepted manuscripts must include a link back to the final published article on ScienceDirect. Please see our sharing policy for more information.

Help and Support